Denali Therapeutics, Inc. (DNLI)
19.30
+0.47
(+2.50%)
USD |
NASDAQ |
May 21, 16:00
17.50
-1.80
(-9.33%)
After-Hours: 19:59
Denali Therapeutics Accounts Payable (Quarterly) : 40.38M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Biogen, Inc. | 358.50M |
| Neurocrine Biosciences, Inc. | 120.00M |
| Arcturus Therapeutics Holdings, Inc. | 4.093M |
| Agenus, Inc. | 71.08M |
| Curis, Inc. | 6.742M |